{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:01:51Z","timestamp":1790164911809,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Obesity is a chronic, relapsing disease associated with substantial morbidity and healthcare burden. Although metabolic and bariatric surgery (MBS) remains the most effective treatment for severe obesity, weight recurrence after sleeve gastrectomy (SG) represents a significant clinical challenge and may require additional therapeutic strategies. Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated substantial efficacy in obesity treatment; however, evidence regarding its use after SG remains limited. This review critically evaluates the current evidence regarding the potential role of tirzepatide in the management of weight recurrence after SG, with particular emphasis on treatment efficacy, safety, body composition, nutritional considerations, and implications for dietetic practice. Methods: A critical review of the literature was conducted using PubMed\/MEDLINE, Scopus, Web of Science, Cochrane Library, and ClinicalTrials.gov databases. Evidence was analyzed according to the population studied, including direct evidence from patients after SG, data from mixed post-bariatric surgery cohorts, and indirect evidence from clinical trials involving individuals with obesity without previous MBS. Results: Available evidence suggests that tirzepatide may induce clinically meaningful weight reduction in patients experiencing weight recurrence after SG; however, direct evidence remains limited and is derived mainly from short-term retrospective studies. Findings from mixed post-bariatric populations and randomized clinical trials in individuals with obesity provide supportive but indirect evidence. Important uncertainties remain regarding long-term efficacy, treatment durability after discontinuation, effects on body composition, preservation of fat-free mass, and nutritional safety. Conclusions: Tirzepatide may represent a valuable adjunctive therapy for selected patients with weight recurrence after SG, particularly when integrated into multidisciplinary obesity management. Nevertheless, current evidence is insufficient to establish its definitive role after SG. Future prospective studies are warranted to evaluate long-term effectiveness, safety, nutritional outcomes, and changes in body composition using standardized definitions of postoperative weight recurrence.<\/jats:p>","DOI":"10.3390\/nu18193131","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:08Z","timestamp":1790161748000},"page":"3131","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tirzepatide\u00a0for Weight Recurrence After Metabolic and Bariatric Surgery: A Critical Review of Direct and Indirect Evidence with Emphasis on Sleeve Gastrectomy, Nutritional Safety, and Clinical Implications"],"prefix":"10.3390","volume":"18","author":[{"given":"Karolina","family":"Cio\u0142kosz","sequence":"first","affiliation":[{"name":"Student Scientific Club of Human Nutrition, Faculty of Health Sciences and Psychology, Collegium Medicum, University of Rzesz\u00f3w, ul. Warzywna 1a, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4766-6398","authenticated-orcid":false,"given":"Ewelina","family":"Polak-Szczyby\u0142o","sequence":"additional","affiliation":[{"name":"Department of Dietetics, Faculty of Health Sciences and Psychology, Collegium Medicum, University of Rzesz\u00f3w, ul. Warzywna 1a, 35-959 Rzeszow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s11695-020-05160-5","article-title":"Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps\u2014A Scoping Review","volume":"31","author":"Elhag","year":"2021","journal-title":"Obes. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1007\/s00464-022-09785-8","article-title":"Weight Recurrence after Sleeve Gastrectomy versus Roux-En-Y Gastric Bypass: A Propensity Score Matched Nationwide Analysis","volume":"37","author":"Akpinar","year":"2023","journal-title":"Surg. Endosc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11695-024-07137-0","article-title":"Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study","volume":"34","author":"Jamal","year":"2024","journal-title":"Obes. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1007\/s11695-025-08414-2","article-title":"Effects of Semaglutide and Tirzepatide on Recurrent Weight Gain After Bariatric Surgery: A Systematic Review and Meta-Analysis","volume":"35","author":"Pouwels","year":"2025","journal-title":"Obes. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s11695-024-07175-8","article-title":"Glucagon-Like Peptide-1 Receptor Agonists in Post-Bariatric Surgery Patients: A Systematic Review and Meta-Analysis","volume":"34","author":"Dutta","year":"2024","journal-title":"Obes. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body Composition Changes during Weight Reduction with Tirzepatide in the SURMOUNT-1 Study of Adults with Obesity or Overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Vieira De Sousa, J.P., Santos-Sousa, H., Vieira, S., Nunes, R., Nogueiro, J., Pereira, A., Resende, F., Costa-Pinho, A., Preto, J., and Sousa-Pinto, B. (2024). Assessing Nutritional Deficiencies in Bariatric Surgery Patients: A Comparative Study of Roux-En-Y Gastric Bypass versus Sleeve Gastrectomy. J. Pers. Med., 14.","DOI":"10.3390\/jpm14060650"},{"key":"ref_8","first-page":"e55062","article-title":"Nutritional Deficiencies Before and After Bariatric Surgery in Low- and High-Income Countries: Prevention and Treatment","volume":"16","author":"Kamal","year":"2024","journal-title":"Cureus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.soard.2016.12.018","article-title":"American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients","volume":"13","author":"Parrott","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and Diagnostic Criteria of Clinical Obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.16263","article-title":"An Overview of Obesity-Related Complications: The Epidemiological Evidence Linking Body Weight and Other Markers of Obesity to Adverse Health Outcomes","volume":"27","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jama.2020.12567","article-title":"Benefits and Risks of Bariatric Surgery in Adults: A Review","volume":"324","author":"Arterburn","year":"2020","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, Regional, and National Prevalence of Adult Overweight and Obesity, 1990\u20132021, with Forecasts to 2050: A Forecasting Study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery","volume":"33","author":"Eisenberg","year":"2023","journal-title":"Obes. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.20897","article-title":"Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-En-Y Gastric Bypass on Weight Loss in Patients with Morbid Obesity: The SM-BOSS Randomized Clinical Trial","volume":"319","author":"Peterli","year":"2018","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamasurg.2020.5666","article-title":"Effect of Laparoscopic Sleeve Gastrectomy vs Roux-En-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients with Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial","volume":"156","author":"Juuti","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jamasurg.2024.7052","article-title":"Long-Term Outcomes of Laparoscopic Roux-En-Y Gastric Bypass vs Laparoscopic Sleeve Gastrectomy for Obesity: The SM-BOSS Randomized Clinical Trial","volume":"160","author":"Peters","year":"2025","journal-title":"JAMA Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.soard.2022.04.012","article-title":"Current State of the Definition and Terminology Related to Weight Recurrence after Metabolic Surgery: Review by the POWER Task Force of the American Society for Metabolic and Bariatric Surgery","volume":"18","author":"Majid","year":"2022","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11892-023-01498-z","article-title":"Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment","volume":"23","author":"Noria","year":"2023","journal-title":"Curr. Diab Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s11695-016-2152-x","article-title":"Weight Regain Following Sleeve Gastrectomy\u2014A Systematic Review","volume":"26","author":"Lauti","year":"2016","journal-title":"Obes. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/jama.2018.14433","article-title":"Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association with Clinical Outcomes","volume":"320","author":"King","year":"2018","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11695-019-04210-x","article-title":"Definitions of Long-Term Weight Regain and Their Associations with Clinical Outcomes","volume":"30","author":"Voorwinde","year":"2020","journal-title":"Obes. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1007\/s11695-025-08359-6","article-title":"Proposed Definitions and Clinical Recommendations for the Management of Weight Recurrence, Partial Response, and Nonresponse Following Metabolic and Bariatric Surgery","volume":"35","author":"Majid","year":"2025","journal-title":"Obes. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lucas, E., Simmons, O., Tchang, B., and Aronne, L. (2023). Pharmacologic Management of Weight Regain Following Bariatric Surgery. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1043595"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/s41591-023-02597-w","article-title":"Tirzepatide after Intensive Lifestyle Intervention in Adults with Overweight or Obesity: The SURMOUNT-3 Phase 3 Trial","volume":"29","author":"Wadden","year":"2023","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: The SURMOUNT-4 Randomized Clinical Trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liu, Q.K. (2024). Mechanisms of Action and Therapeutic Applications of GLP-1 and Dual GIP\/GLP-1 Receptor Agonists. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1431292"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/oby.24336","article-title":"Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"33","author":"Mozaffarian","year":"2025","journal-title":"Obesity"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People with Type 2 Diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11695-022-06444-8","article-title":"Change in Adipokines and Gastrointestinal Hormones after Bariatric Surgery: A Meta-Analysis","volume":"33","author":"Huang","year":"2023","journal-title":"Obes. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1017\/S0007114522000381","article-title":"Role of Cholecystokinin in Satiation: A Systematic Review and Meta-Analysis","volume":"129","author":"Warrilow","year":"2023","journal-title":"Br. J. Nutr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/1753-0407.13443","article-title":"Mechanisms of Bariatric Surgery for Weight Loss and Diabetes Remission","volume":"15","author":"Yin","year":"2023","journal-title":"J. Diabetes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e12721","DOI":"10.1111\/cob.12721","article-title":"Changes in Gastrointestinal Motility and Gut Hormone Secretion after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Individuals with Severe Obesity","volume":"15","author":"Wilbrink","year":"2025","journal-title":"Clin. Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/db22-0568","article-title":"The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and \u03b2-Cell Function After Roux-En-Y Gastric Bypass and Sleeve Gastrectomy Surgery","volume":"72","author":"Svane","year":"2023","journal-title":"Diabetes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1007\/s11695-025-08168-x","article-title":"GLP-1 and GIP Changes after Sleeve Gastrectomy and Weight Regain in Adolescents. Do We Need a Boost?","volume":"35","author":"Shehata","year":"2025","journal-title":"Obes. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/s41591-025-03774-9","article-title":"Tirzepatide on Ingestive Behavior in Adults with Overweight or Obesity: A Randomized 6-Week Phase 1 Trial","volume":"31","author":"Martin","year":"2025","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.orcp.2025.02.004","article-title":"Tackling Suboptimal Clinical Response after Metabolic Bariatric Surgery: Impact of Tirzepatide on Weight Loss and Body Composition","volume":"19","author":"Stoll","year":"2025","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1007\/s11695-026-08754-7","article-title":"Tirzepatide for Recurrent Weight Gain after Bariatric Procedures: Real-World Evidence of Efficacy and Safety","volume":"36","author":"Vinciguerra","year":"2026","journal-title":"Obes. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1007\/s00464-025-11942-8","article-title":"Sleeve-to-Bypass Conversion vs. Sleeve-with-Adjuvant GLP-1 Receptor Agonists: An Academic Multicenter Retrospective Study","volume":"39","author":"Brown","year":"2025","journal-title":"Surg. Endosc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s11096-024-01779-x","article-title":"Efficacy and Safety of Tirzepatide versus Placebo in Overweight or Obese Adults without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"46","author":"Liu","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes (SURMOUNT-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5144\/0256-4947.2025.129","article-title":"Gastrointestinal Safety of Semaglutide and Tirzepatide vs. Placebo in Obese Individuals without Diabetes: A Systematic Review and Meta Analysis","volume":"45","author":"Safwan","year":"2025","journal-title":"Ann. Saudi Med."},{"key":"ref_45","unstructured":"(2026, July 27). Tirzepatide Injection (Zepbound\u00ae): Basic Information for Prescribers\u2014Simple and Practical Mental Health. Available online: https:\/\/simpleandpractical.com\/tirzepatide-zepbound\/."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zeng, Q., Xu, J., Mu, X., Shi, Y., Fan, H., and Li, S. (2023). Safety Issues of Tirzepatide (Pancreatitis and Gallbladder or Biliary Disease) in Type 2 Diabetes and Obesity: A Systematic Review and Meta-Analysis. Front. Endocrinol., 14, Correction in Front. Endocrinol.\u00a02024, 15, 1342543. https:\/\/doi.org\/10.3389\/fendo.2024.1342543.","DOI":"10.3389\/fendo.2023.1214334"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e13087","DOI":"10.1111\/obr.13087","article-title":"British Obesity and Metabolic Surgery Society Guidelines on Perioperative and Postoperative Biochemical Monitoring and Micronutrient Replacement for Patients Undergoing Bariatric Surgery\u20142020 Update","volume":"21","author":"Parretti","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3945\/an.116.014258","article-title":"Nutritional Recommendations for Adult Bariatric Surgery Patients: Clinical Practice","volume":"8","author":"Goldenshluger","year":"2017","journal-title":"Adv. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13679-025-00607-1","article-title":"Is There a Need to Reassess Protein Intake Recommendations Following Metabolic Bariatric Surgery?","volume":"14","author":"Lahav","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12937-021-00688-3","article-title":"The Effect of Additional Protein on Lean Body Mass Preservation in Post-Bariatric Surgery Patients: A Systematic Review","volume":"20","author":"Romeijn","year":"2021","journal-title":"Nutr. J."},{"key":"ref_51","first-page":"1","article-title":"The Relationship between Protein Intake and Body Composition after Bariatric Surgery: Influence of Sex and Type of Surgery","volume":"54","author":"Landecho","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"156113","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of Glucagon-like Peptide-1 Receptor Agonists and Co-Agonists on Body Composition: Systematic Review and Network Meta-Analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e13370","DOI":"10.1111\/obr.13370","article-title":"The Magnitude and Progress of Lean Body Mass, Fat-free Mass, and Skeletal Muscle Mass Loss Following Bariatric Surgery: A Systematic Review and Meta-analysis","volume":"23","author":"Nuijten","year":"2022","journal-title":"Obes. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"111577","DOI":"10.1016\/j.nut.2021.111577","article-title":"Nutrient and Fluid Requirements in Post-Bariatric Patients Performing Physical Activity: A Systematic Review","volume":"97","author":"Stocker","year":"2022","journal-title":"Nutrition"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/SLA.0000000000003614","article-title":"Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-Analysis","volume":"272","author":"McCarty","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1007\/s11695-020-04837-1","article-title":"Resistance Training in Post-Metabolic and Bariatric Surgery Patients: A Systematic Review","volume":"30","author":"Kohl","year":"2020","journal-title":"Obes. Surg."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/19\/3131\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:17:00Z","timestamp":1790162220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/19\/3131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":56,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["nu18193131"],"URL":"https:\/\/doi.org\/10.3390\/nu18193131","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}